Form 4: Roivant Sciences Director Keith Manchester Receives Stock Options and Restricted Stock Units

Keith Manchester, a director of Roivant Sciences Ltd., was granted stock options and restricted stock units (RSUs) as part of the company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.

Summary

• Keith Manchester, a director at Roivant Sciences Ltd., received an annual award of 16,406 restricted stock units (RSUs) on September 10, 2024, under the company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
• These RSUs will vest 100% on September 10, 2025, contingent upon Manchester's continuous service through that date.
• Manchester also received an annual award of stock options to purchase 27,894 Common Shares on September 10, 2024, also under the 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
• These stock options, with an exercise price of $12.19, will vest and become exercisable 100% on September 10, 2025, subject to continuous service.
• Following these transactions, Manchester beneficially owns 1,780,178 Common Shares and 27,894 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard compensation practices, indicating stability and alignment of interests.

Positives

• The grant of RSUs and stock options aligns the director's interests with the company's long-term performance.
• The vesting schedule incentivizes continued service and commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the granted securities.

Industry Context

This type of equity compensation is standard practice for directors of publicly traded companies to align their interests with shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across the pharmaceutical and biotech industries.
• Companies like Amgen, Gilead, and Biogen also utilize stock options and restricted stock units as part of their director compensation packages.
• The specific amounts and vesting schedules vary based on company size, performance, and individual contributions.

Stakeholder Impact

• The equity grants align the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates